Kathrin Kizina

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Safety and feasibility of tumor treating fields initiated before and during radiotherapy for newly diagnosed glioblastoma: results from the Arm A feasibility cohort of a phase I/II trial (PriCoTTF).

Safety and feasibility of tumor treating fields initiated before and during radiotherapy for newly diagnosed glioblastoma: results from the Arm A feasibility cohort of a phase I/II trial (PriCoTTF).

Journal: BMC cancer

Published: June 18, 2026

Phosphorylated mTOR immunohistochemistry-guided use of temsirolimus in recurrent IDH-wildtype glioblastoma: a real-world retrospective series.

Phosphorylated mTOR immunohistochemistry-guided use of temsirolimus in recurrent IDH-wildtype glioblastoma: a real-world retrospective series.

Journal: Journal of cancer research and clinical oncology

Published: February 02, 2026

COVID-19 and Influenza Booster Vaccination Elicits Robust Antibody Responses in Patients with Primary Brain Tumors Comparable to Healthy Adults.

COVID-19 and Influenza Booster Vaccination Elicits Robust Antibody Responses in Patients with Primary Brain Tumors Comparable to Healthy Adults.

Journal: Cancers

Published: October 26, 2025

Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?

Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?

Journal: Neuro-oncology advances

Published: May 15, 2025

Decoding glioblastoma survival: unraveling the prognostic potential of olfactory function in a prospective observational study.

Decoding glioblastoma survival: unraveling the prognostic potential of olfactory function in a prospective observational study.

Journal: Neurological research and practice

Published: May 09, 2025

Assessment of Health-Related Quality of Life in Adult Spinal Muscular Atrophy Under Nusinersen Treatment-A Pilot Study.

Assessment of Health-Related Quality of Life in Adult Spinal Muscular Atrophy Under Nusinersen Treatment-A Pilot Study.

Journal: Frontiers in neurology

Published: November 09, 2021

Assessment of Bulbar Function in Adult Patients with 5q-SMA Type 2 and 3 under Treatment with Nusinersen.

Assessment of Bulbar Function in Adult Patients with 5q-SMA Type 2 and 3 under Treatment with Nusinersen.

Journal: Brain sciences

Published: August 16, 2021

Cognitive Impairment in Adult Patients with 5q-Associated Spinal Muscular Atrophy.

Cognitive Impairment in Adult Patients with 5q-Associated Spinal Muscular Atrophy.

Journal: Brain sciences

Published: July 26, 2021

Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parameters.

Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parameters.

Journal: Journal of neurology

Published: March 02, 2021

Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study.

Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study.

Journal: Therapeutic advances in neurological disorders

Published: January 03, 2021

Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy.

Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy.

Journal: eNeurologicalSci

Published: October 06, 2020

Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy.

Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy.

Journal: European journal of neurology

Published: April 24, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026